Drug Treatment Reduces PD-L1 Levels in Glioblastoma (IMAGE)
Caption
Compared with a control (left), treatment with the drug MK2206 (right) reduces the levels of PD-L1 (brown) in glioblastoma cells in mice.
Credit
©2020 Du et al. Originally published in <em>Journal of Experimental Medicine</em>. https://doi.org/10.1084/jem.20191115
Usage Restrictions
Reporters may freely use these materials in news coverage with the appropriate credit information.
License
Licensed content